Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accounts Payables: 2011-2017

Historic Accounts Payables for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $579,386.

  • Tenax Therapeutics' Accounts Payables fell 58.39% to $579,386 in Q3 2017 from the same period last year, while for Sep 2017 it was $579,386, marking a year-over-year decrease of 58.39%. This contributed to the annual value of $727,599 for FY2016, which is N/A change from last year.
  • Tenax Therapeutics' Accounts Payables amounted to $579,386 in Q3 2017, which was up 33.44% from $434,195 recorded in Q2 2017.
  • Tenax Therapeutics' Accounts Payables' 5-year high stood at $1.5 million during Q2 2016, with a 5-year trough of $434,195 in Q2 2017.
  • Over the past 3 years, Tenax Therapeutics' median Accounts Payables value was $972,483 (recorded in 2015), while the average stood at $1.0 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 80.02% in 2013, then tumbled by 71.46% in 2017.
  • Over the past 4 years, Tenax Therapeutics' Accounts Payables (Quarterly) stood at $977,162 in 2013, then reached $972,483 in 2015, then decreased by 25.18% to $727,599 in 2016, then tumbled by 58.39% to $579,386 in 2017.
  • Its Accounts Payables was $579,386 in Q3 2017, compared to $434,195 in Q2 2017 and $1.4 million in Q1 2017.